ARTELO BIOSCIENCES, INC. Quarterly Current Ratio in % from Q2 2016 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Artelo Biosciences, Inc. quarterly Current Ratio history and growth rate from Q2 2016 to Q3 2024.
  • Artelo Biosciences, Inc. Current Ratio for the quarter ending September 30, 2024 was 831 %, a 55.7% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 831 -1.04K -55.7% Sep 30, 2024
Q2 2024 1K -1.39K -58.2% Jun 30, 2024
Q1 2024 1.33K -1.4K -51.1% Mar 31, 2024
Q4 2023 1.52K -1.45K -48.7% Dec 31, 2023
Q3 2023 1.87K -1.28K -40.6% Sep 30, 2023
Q2 2023 2.4K -373 -13.5% Jun 30, 2023
Q1 2023 2.73K +283 +11.6% Mar 31, 2023
Q4 2022 2.97K +762 +34.5% Dec 31, 2022
Q3 2022 3.16K +1.2K +61.6% Sep 30, 2022
Q2 2022 2.77K +1.19K +75.5% Jun 30, 2022
Q1 2022 2.45K +1.22K +98.9% Mar 31, 2022
Q4 2021 2.21K +1.42K +180% Dec 31, 2021
Q3 2021 1.95K +1.43K +273% Aug 31, 2021
Q2 2021 1.58K +1.08K +218% May 31, 2021
Q1 2021 1.23K +865 +237% Feb 28, 2021
Q4 2020 789 +536 +213% Nov 30, 2020
Q3 2020 523 +361 +223% Aug 31, 2020
Q2 2020 497 +431 +661% May 31, 2020
Q1 2020 365 +315 +618% Feb 29, 2020
Q4 2019 252 +177 +234% Nov 30, 2019
Q3 2019 162 +43 +36.2% Aug 31, 2019
Q2 2019 65.3 -132 -67% May 31, 2019
Q1 2019 50.9 -162 -76.1% Feb 28, 2019
Q4 2018 75.5 -155 -67.2% Nov 30, 2018
Q3 2018 119 -78.9 -39.9% Aug 31, 2018
Q2 2018 198 +136 +220% May 31, 2018
Q1 2018 213 +180 +544% Feb 28, 2018
Q4 2017 230 +201 +678% Nov 30, 2017
Q3 2017 198 +162 +460% Aug 31, 2017
Q2 2017 61.8 -46.2 -42.8% May 31, 2017
Q1 2017 33 Feb 28, 2017
Q4 2016 29.6 Nov 30, 2016
Q3 2016 35.3 Aug 31, 2016
Q2 2016 108 May 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.